1. Home
  2. SDA vs ICCC Comparison

SDA vs ICCC Comparison

Compare SDA & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SDA

SunCar Technology Group Inc.

HOLD

Current Price

$0.52

Market Cap

79.8M

Sector

Finance

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$9.58

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDA
ICCC
Founded
2007
1982
Country
China
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.8M
93.1M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
SDA
ICCC
Price
$0.52
$9.58
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
409.0K
20.2K
Earning Date
04-28-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.41
Revenue
N/A
$26,493,169.00
Revenue This Year
$12.01
N/A
Revenue Next Year
$15.55
N/A
P/E Ratio
N/A
$24.02
Revenue Growth
N/A
51.64
52 Week Low
$0.42
$4.52
52 Week High
$2.78
$12.10

Technical Indicators

Market Signals
Indicator
SDA
ICCC
Relative Strength Index (RSI) 39.02 37.52
Support Level $0.47 $9.55
Resistance Level $0.86 $10.75
Average True Range (ATR) 0.09 0.25
MACD -0.01 0.01
Stochastic Oscillator 47.80 10.76

Price Performance

Historical Comparison
SDA
ICCC

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: